Hypothesis

Chronic suppression of COX-2-derived prostaglandins by NSAIDs diminishes neurogenic release of substance P and CGRP, which normally activate macrophage MRGPRX2-dependent clearance of senescent tubular cells. Loss of this signal leads to accumulation of p16INK4a/p21-positive cells, accelerated nephron attrition, and faster age-related decline in kidney function.

Mechanistic Rationale

COX-2 in injured tubules generates PGE2 that binds EP4 receptors on resident macrophages, raising cAMP and promoting a phagocytic phenotype. Simultaneously, released substance P and CGRP act on MRGPRX2 on the same macrophages, triggering degranulation of proteases that remodel the extracellular matrix and expose senescent-cell surface ligands for recognition. NSAID blockade of COX-2 cuts both PGE2 and the neuropeptide burst, leaving macrophages in a resting state unable to eliminate senescent cells. Consequently, senescent tubular cells persist, secrete SASP factors, and drive paracrine senescence to podocytes and endothelium, amplifying nephron loss.

Experimental Design

1. Animal model – Aged (18‑month) C57BL/6 mice receive either vehicle, chronic low‑dose ibuprofen (50 mg/kg/day) or ibuprofen plus intrarenal substance P (1 µg/day) via osmotic pump for 12 weeks.
2. Readouts –
   • qPCR and immunofluorescence for p16INK4a, p21, and SASP cytokines (IL‑6, PAI‑1) in isolated tubules.
   • Flow cytometry of kidney digests for F4/80^+CD206^+ macrophages, EP4 and MRGPRX2 expression, and intracellular cAMP.
   • Measurement of macrophage phagocytic activity using pHrodo‑labeled senescent tubular cell fragments ex vivo.
   • Serum creatinine, BUN, and histology for glomerulosclerosis and tubular atrophy.
3. Rescue test – Substance P administration to ibuprofen‑treated mice to assess whether neuropeptide replacement restores macrophage clearance and reduces senescence markers.
4. Human correlation – Analyze existing cohorts (e.g., NIH CKD registry) for association between long‑term NSAID prescription density and urinary p16‑positive tubular epithelial cell counts, adjusting for age, hypertension, diabetes.

Expected Outcomes

• Ibuprofen alone will increase tubular p16INK4a/p21 protein levels (~1.8‑fold vs vehicle) and elevate SASP mRNA, coinciding with reduced EP4/cAMP signaling and lowered MRGPRX2‑dependent degranulation markers in macrophages.
• Exogenous substance P will normalize macrophage cAMP, enhance phagocytosis of senescent cell fragments, and bring p16/p21 levels back to vehicle ranges, while improving creatinine clearance.
• In human data, high NSAID exposure will correlate with higher urinary senescence markers independent of comorbidities.

Potential Caveats

Compensatory upregulation of COX‑1 may mask effects; using selective COX‑2 inhibitors (celecoxib) in parallel arms can clarify specificity. Substance P may activate nociceptive pathways; dosing must avoid pain‑behavior confounders, which we will monitor via von Frey testing. Finally, macrophage heterogeneity may require single‑cell RNA‑seq to identify the precise subset responsible for clearance.